Mary Ann Liebert, Journal of Ocular Pharmacology and Therapeutics, 9(29), p. 786-793, 2013
Full text: Unavailable
In this review, we aim to summarize the currently available compounds targeting the different components of the inflammatory cascade triggered by an ocular allergic reaction, from mast cells to eosinophils and lymphocytes, with a special focus on specific signs and symptoms that are related to them.